Wegovy (Semaglutide) — Complete UK Guide
What is Wegovy?
Wegovy (semaglutide 2.4mg) is a prescription weight management medication approved in the UK. It's a GLP-1 receptor agonist that helps reduce appetite and calorie intake, leading to clinically significant weight loss.
How does it work?
Wegovy mimics the GLP-1 hormone, which is naturally released after eating. It acts on the brain to reduce appetite and feelings of hunger, slows gastric emptying so you feel full longer, and helps regulate blood sugar levels.
GPhC-registered UK pharmacy. Same-day prescription, next-day delivery from EverydayMeds.
Wegovy doses & expected weight loss
Based on STEP trial data over 68 weeks
| Dose | Avg Weight Loss | Notes |
|---|---|---|
| 0.25mg | ~3% | Starting dose — weeks 1–4 |
| 0.5mg | ~5% | Weeks 5–8 |
| 1mg | ~8% | Weeks 9–12 |
| 1.7mg | ~11% | Weeks 13–16 |
| 2.4mg | ~14.9% | Maximum maintenance dose |
Dose escalation timeline
Who is eligible?
- BMI of 30 or above (obese)
- BMI of 27.5 or above with a weight-related health condition
- BMI of 23 or above for South Asian patients
- Must be aged 18 or over
Weight Loss
Same-day prescription from a GPhC-registered UK pharmacy. Next-day DPD delivery.
Side effects
- Nausea
- Diarrhoea
- Constipation
- Headache
- Vomiting
- Abdominal pain
- Fatigue
Most side effects are temporary and lessen over time as your body adjusts.
Wegovy vs Mounjaro
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Drug name | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 only | Dual GIP + GLP-1 |
| Max weight loss | ~14.9% | ~20.9% |
| Max dose | 2.4mg weekly | 15mg weekly |
| Administration | Weekly injection | Weekly injection |